CTOs on the Move

II-VI

www.ii-vi.com

 
II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in the industrial, optical communications, military, life sciences, semiconductor equipment, and consumer markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to enable our customers.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.ii-vi.com
  • 375 Saxonburg Boulevard
    Saxonburg, PA USA 16056
  • Phone: 724.352.4455

Executives

Name Title Contact Details
James McEvoy
 Vice President, Information Technology, II-VI Aerospace and Defense Profile
Kevin Varley
 Director of Information Security and Compliance Profile

Funding

II-VI raised $410M on 05/07/2021

Similar Companies

Xytex Sperm Bank

Xytex Sperm Bank is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oliver-Tolas Healthcare Packaging

Oliver-Tolas Healthcare Packaging is one of the world's leading producers of sterile-grade medical device packaging and pharmaceutical packaging. Oliver-Tolas brings together the best of Oliver Medical Packaging and Tolas Healthcare Packaging's 30+ years producing the industry's highest quality and most innovative products.

Sonoma Orthopedic Products Inc

Sonoma Orthopedic Products Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Mikron Digital Imaging

Mikron Digital Imaging is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zenflow

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.